The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Open accessAbstract
BACKGROUND: We tested the hypothesis that the level of circulating tumor cells can predict survival in metastatic breast cancer. METHODS: In a prospective, multicenter study, we tested 177 patients with measurable metastatic breast cancer for levels of circulating tumor cells both before the patients were to start a new line of treatment and at the first follow-up visit. The progression of the disease or the response to treatment was determined with the use of standard imaging studies at the participating centers. RESULTS: Outcomes were assessed according to levels of circulating tumor cells at baseline, before the patients started a new treatment for metastatic disease. Patients in a training set with levels of circulating tumor cells equal to or higher than 5 per 7.5 ml of whole blood, as compared with the group with fewer than 5 circulating tumor cells per 7.5 ml, had a shorter median progression-free survival (2.7 months vs. 7.0 months, P<0.001) and shorter overall survival (10.1 months vs. >18 months, P<0.001). At the first follow-up visit after the initiation of therapy, this difference between the groups persisted (progression-free survival, 2.1 months vs. 7.0 months; P<0.001; overall survival, 8.2 months vs. >18 months; P<0.001), and the reduced proportion of patients (from 49 percent to 30 percent) in the group with an unfavorable prognosis suggested that there was a benefit from therapy. The multivariate Cox proportional-hazards regression showed that, of all the variables in the statistical model, the levels of circulating tumor cells at baseline and at the first follow-up visit were the most significant predictors of progression-free and overall survival. CONCLUSIONS: The number of circulating tumor cells before treatment is an independent predictor of progression-free survival and overall survival in patients with metastatic breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,135
Self-citationPrinted covalent glycan array for ligand profiling of diverse glycan binding proteins
Blixt, O., Head, S., Mondala, T., Scanlan, C., Huflejt, M. E., Alvarez, R., Bryan, M. C., Fazio, F., Calarese, D., Stevens, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407902101 · Cited by 1,101
O’Shaughnessy, J., Miles, D., Vukelja, S., Moiseyenko, V., Ayoub, J.-P., Cervantes, G., Fumoleau, P., Jones, S., Lui, W.-Y., Mauriac, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.002 · Cited by 1,081
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1110 · Cited by 971
Self-citation
Cited by
Items 201–248 of 248
Lymphatic or Hematogenous Dissemination: How Does a Metastatic Tumor Cell Decide?
Wong, S. Y., & Hynes, R. O. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2646 · Cited by 266
Lianidou, E. S., & Markou, A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165068 · Cited by 265
Fluorescent biosensors enabled by graphene and graphene oxide
Zhang, H., Zhang, H., Aldalbahi, A., Zuo, X., Fan, C., & Mi, X. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.07.030 · Cited by 264
Nucleic Acid Tests for Clinical Translation
Li, M., Yin, F., Song, L., Mao, X., Li, F., Fan, C., Zuo, X., & Xia, Q. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00241 · Cited by 264
Zhou, H., Zhu, L., Song, J., Wang, G., Li, P., Li, W., Luo, P., Sun, X., Wu, J., Liu, Y., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01556-2 · Cited by 261
Capture and Stimulated Release of Circulating Tumor Cells on Polymer‐Grafted Silicon Nanostructures
Hou, S., Zhao, H., Zhao, L., Shen, Q., Wei, K. S., Suh, D. Y., Nakao, A., Garcia, M. A., Song, M., Lee, T., et al. (2013) · Advanced Materials · doi:10.1002/adma.201203185 · Cited by 260
Better together: circulating tumor cell clustering in metastatic cancer
Schuster, E., Taftaf, R., Reduzzi, C., Albert, M. K., Romero-Calvo, I., & Liu, H. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2021.07.001 · Cited by 260
Circulating tumour cells: their utility in cancer management and predicting outcomes
Krebs, M. G., Hou, J.-M., Ward, T. H., Blackhall, F. H., & Dive, C. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010378414 · Cited by 259
EMT: Present and future in clinical oncology
Santamaria, P. G., Moreno‐Bueno, G., Portillo, F., & Cano, A. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12091 · Cited by 259
Cancer Diagnosis: From Tumor to Liquid Biopsy and Beyond
Vaidyanathan, R., Soon, R. H., Zhang, P., Jiang, K., & Lim, C. T. (2018) · Lab on a Chip · doi:10.1039/c8lc00684a · Cited by 259
Taftaf, R., Liu, X., Singh, S., Jia, Y., Dashzeveg, N. K., Hoffmann, A. D., El-Shennawy, L., Ramos, E. K., Adorno-Cruz, V., Schuster, E. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25189-z · Cited by 261
Self-citationSheng, W., Ogunwobi, O. O., Chen, T., Zhang, J., George, T. J., Liu, C., & Fan, Z. H. (2014) · Lab Chip · doi:10.1039/c3lc51017d · Cited by 257
Circulating Epithelial Cells in Patients with Benign Colon Diseases
Pantel, K., Denève, E., Nocca, D., Coffy, A., Vendrell, J.-P., Maudelonde, T., Riethdorf, S., & Alix-Panabières, C. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.175570 · Cited by 255
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
Khoja, L., Backen, A., Sloane, R., Menasce, L., Ryder, D., Krebs, M., Board, R., Clack, G., Hughes, A., Blackhall, F., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.545 · Cited by 255
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
Febbo, P. G., Ladanyi, M., Aldape, K. D., De Marzo, A. M., Hammond, M. E., Hayes, D. F., Iafrate, A. J., Kelley, R. K., Marcucci, G., Ogino, S., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0137 · Cited by 255
Self-citationMolecular profiling of single circulating tumor cells with diagnostic intention
Polzer, B., Medoro, G., Pasch, S., Fontana, F., Zorzino, L., Pestka, A., Andergassen, U., Meier‐Stiegen, F., Czyz, Z. T., Alberter, B., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404033 · Cited by 254
Boire, A., Brandsma, D., Brastianos, P. K., Le Rhun, E., Ahluwalia, M., Junck, L., Glantz, M., Groves, M. D., Lee, E. Q., Lin, N., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz012 · Cited by 183
Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers
Murlidhar, V., Reddy, R. M., Fouladdel, S., Zhao, L., Ishikawa, M. K., Grabauskiene, S., Zhang, Z., Lin, J., Chang, A. C., Carrott, P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2072 · Cited by 181
Khoo, B. L., Grenci, G., Lim, Y. B., Lee, S. C., Han, J., & Lim, C. T. (2018) · Nature Protocols · doi:10.1038/nprot.2017.125 · Cited by 172
Earhart, C. M., Hughes, C. E., Gaster, R. S., Ooi, C. C., Wilson, R. J., Zhou, L. Y., Humke, E. W., Xu, L., Wong, D. J., Willingham, S. B., et al. (2014) · Lab Chip · doi:10.1039/c3lc50580d · Cited by 165
Nemunaitis, J., Nemunaitis, M., Senzer, N., Snitz, P., Bedell, C., Kumar, P., Pappen, B., Maples, P. B., Shawler, D., & Fakhrai, H. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.15 · Cited by 147
Liquid biopsy in the clinical management of hepatocellular carcinoma
von Felden, J., Garcia-Lezana, T., Schulze, K., Losic, B., & Villanueva, A. (2020) · Gut · doi:10.1136/gutjnl-2019-320282 · Cited by 141
Biomarkers for early detection of breast cancer: What, when, and where?
LEVENSON, V (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.017 · Cited by 131
Yan, W.-T., Cui, X., Chen, Q., Li, Y.-F., Cui, Y.-H., Wang, Y., & Jiang, J. (2017) · Scientific Reports · doi:10.1038/srep43464 · Cited by 113
Simpson, C. D., Mawji, I. A., Anyiwe, K., Williams, M. A., Wang, X., Venugopal, A. L., Gronda, M., Hurren, R., Cheng, S., Serra, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2530 · Cited by 104
Plouffe, B. D., Mahalanabis, M., Lewis, L. H., Klapperich, C. M., & Murthy, S. K. (2012) · Analytical Chemistry · doi:10.1021/ac2022844 · Cited by 96
An integrated microfluidic chip for one-step isolation of circulating tumor cells
Lee, T. Y., Hyun, K.-A., Kim, S.-I., & Jung, H.-I. (2017) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2016.05.163 · Cited by 94
Song, J., Miermont, A., Lim, C. T., & Kamm, R. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-36381-5 · Cited by 87
García, J. M., García, V., Peña, C., Domínguez, G., Silva, J., Diaz, R., Espinosa, P., Citores, M. J., Collado, M., & Bonilla, F. (2008) · RNA · doi:10.1261/rna.755908 · Cited by 86
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis
Gross, A. C., Cam, H., Phelps, D. A., Saraf, A. J., Bid, H. K., Cam, M., London, C. A., Winget, S. A., Arnold, M. A., Brandolini, L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99791 · Cited by 82
Bhagwat, N., Dulmage, K., Pletcher, C. H., Wang, L., DeMuth, W., Sen, M., Balli, D., Yee, S. S., Sa, S., Tong, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23217-5 · Cited by 75
Zhu, Y., Podolak, J., Zhao, R., Shukla, A. K., Moore, R. J., Thomas, G. V., & Kelly, R. T. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03268 · Cited by 75
Separation and detection of rare cells in a microfluidic disk via negative selection
Chen, C.-L., Chen, K.-C., Pan, Y.-C., Lee, T.-P., Hsiung, L.-C., Lin, C.-M., Chen, C.-Y., Lin, C.-H., Chiang, B.-L., & Wo, A. M. (2011) · Lab Chip · doi:10.1039/c0lc00332h · Cited by 72
Kurzeder, C., Nguyen-Sträuli, B. D., Krol, I., Ring, A., Castro-Giner, F., Nüesch, M., Asawa, S., Zhang, Y. W., Budinjas, S., Gvozdenovic, A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03486-6 · Cited by 64
“The presence of CTCs has been firmly established to be predictive of poor prognosis in patients with breast cancer 7 .”
Application of liquid biopsy in bone and soft tissue sarcomas: Present and future
Li, X., Seebacher, N. A., Hornicek, F. J., Xiao, T., & Duan, Z. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.012 · Cited by 53
Recent advances in microfluidic methods in cancer liquid biopsy
Iliescu, F. S., Poenar, D. P., Yu, F., Ni, M., Chan, K. H., Cima, I., Taylor, H. K., Cima, I., & Iliescu, C. (2019) · Biomicrofluidics · doi:10.1063/1.5087690 · Cited by 51
Martín, M., Custodio, S., Casas, M.-L. M., García-Sáenz, J.-Á., Torre, J.-C., Bellón-Cano, J.-M., López-Tarruella, S., Vidaurreta-Lazaro, M., Orden, V., Jerez, Y., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0479 · Cited by 41
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
Adams, D. L., Adams, D. K., Stefansson, S., Haudenschild, C., Martin, S. S., Charpentier, M., Chumsri, S., Cristofanilli, M., Tang, C.-M., & Alpaugh, R. K. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0706-4 · Cited by 40
Self-citationCirculating microRNAs as Promising Tumor Biomarkers
(2014) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2014.09.007 · Cited by 40
Micro/nanofluidic technologies for efficient isolation and detection of circulating tumor cells
Yue, W.-Q., Tan, Z., Li, X.-P., Liu, F.-F., & Wang, C. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.06.009 · Cited by 34
Park, E. S., Yan, J. P., Ang, R. A., Lee, J. H., Deng, X., Duffy, S. P., Beja, K., Annala, M., Black, P. C., Chi, K. N., et al. (2018) · Lab on a Chip · doi:10.1039/c8lc00184g · Cited by 34
Wu, Z.-J., Tan, J.-C., Qin, X., Liu, B., & Yuan, Z.-C. (2018) · Cancer Management and Research · doi:10.2147/cmar.s176515 · Cited by 33
“8,9 EpCAM is expressed exclusively in epithelia and epithelial-derived neoplasms.”
Xue, M., Xiang, A., Guo, Y., Wang, L., Wang, R., Wang, W., Ji, G., & Lu, Z. (2019) · RSC Advances · doi:10.1039/c9ra08285a · Cited by 26
Negishi, R., Takai, K., Tanaka, T., Matsunaga, T., & Yoshino, T. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00896 · Cited by 24
Yap, Y.-S., Leong, M. C., Chua, Y. W., Loh, K. W. J., Lee, G. E., Lim, E. H., Dent, R., Ng, R. C. H., Lim, J. H.-C., Singh, G., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0221305 · Cited by 23
“Long-term patient outcomes are influenced by biological risk factors such as cancer subtypes, the extent and site of metastatic lesion, and the level of circulating tumour cells (CTCs) [1, 2].”
BackgroundResultInfluentialAssociation of circulating tumor cells and IMP3 expression with metastasis of osteosarcoma
Dai, S., Shao, X., Wei, Q., Du, S., Hou, C., Li, H., & Jin, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.819357 · Cited by 20
An integrated microfluidic platform for negative selection and enrichment of cancer cells 6
Luo, W.-Y., Tsai, S.-C., Hsieh, K., & Lee, G.-B. (2015) · Journal of Micromechanics and Microengineering · doi:10.1088/0960-1317/25/8/084007 · Cited by 18
Walter, K., Tiwary, K., Trajkovic-Arsic, M., Hidalgo-Sastre, A., Dierichs, L., Liffers, S. T., Gu, J., Gout, J., Schulte, L.-A., Münch, J., et al. (2019) · Stem Cells International · doi:10.1155/2019/8475389 · Cited by 16
Metadata
- Authors
- Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., & Hayes, D. F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-19
- Volume
- 351
- Issue
- 8
- Pages
- 781-791
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2111976640
- Cited by
- 4,593
- References
- 30
- FWCI
- 28.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.